APIMEDS PHARMACEUTICALS US, INC. Increase Decrease In Operating Lease Liability
APIMEDS PHARMACEUTICALS US, INC. (APUS) reported Increase Decrease In Operating Lease Liability of -$7.64 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-14
- APIMEDS PHARMACEUTICALS US, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$9.76K.
- APIMEDS PHARMACEUTICALS US, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was $2.12K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month |
|---|---|---|
| 2026-06-30 | -$9.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$7.64K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $2.12K 10-Q · filed 2026-05-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |